Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy - Wikidata - awgldk - TriplyDB

Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy

Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy

http://www.wikidata.org/entity/Q28304865

about

Cancer cell death enhances the penetration and efficacy of oncolytic herpes simplex virus in tumors Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini Combining [11C]-AnxA5 PET imaging with serum biomarkers for improved detection in live mice of modest cell death in human solid tumor xenografts A small molecule with anticancer and antimetastatic activities induces rapid mitochondrial-associated necrosis in breast cancer.APOMAB, a La-specific monoclonal antibody, detects the apoptotic tumor response to life-prolonging and DNA-damaging chemotherapy.Circulating cell death products predict clinical outcome of colorectal cancer patients Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer.Circulating proteolytic signatures of chemotherapy-induced cell death in humans discovered by N-terminal labeling.Sampling the N-terminal proteome of human blood.Automated identification of circulating tumor cells by image cytometry.Serum markers of hepatocyte death and apoptosis are non invasive biomarkers of severe fibrosis in patients with alcoholic liver disease.A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumors Transcriptional profiling provides insights into metronomic cyclophosphamide-activated, innate immune-dependent regression of brain tumor xenografts Evaluation of pharmacodynamic biomarkers in a Phase 1a trial of dulanermin (rhApo2L/TRAIL) in patients with advanced tumours.Quantitative interactome analysis reveals a chemoresistant edgotype.Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trial.Chemotherapy increases caspase-cleaved cytokeratin 18 in the serum of breast cancer patients Biomarker method validation in anticancer drug development Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer.Circulating biomarkers of cell death after treatment with the BH-3 mimetic ABT-737 in a preclinical model of small-cell lung cancer.Circulating Levels of M30 and M65 Molecules in Transitional Cell Carcinoma of the Bladder and Their Relation to Tumor Progression.Roux-En Y Gastric Bypass Results in Long-Term Remission of Hepatocyte Apoptosis and Hepatic Histological Features of Non-alcoholic Steatohepatitis.Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy Cytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumour response.Biomarkers of apoptosis.Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors.The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy.Utilization of cytokeratin-based biomarkers for pharmacodynamic studies.Serum efficacy biomarkers for oncology.Harnessing the cell death pathway for targeted cancer treatment.Advancements in the use of blood tests for cancer screening in women at high risk for endometrial and breast cancer.Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients.Effect of Helix aspersa extract on TNFα, NF-κB and some tumor suppressor genes in breast cancer cell line Hs578T.The M30 assay does not detect apoptosis in epithelial-derived cancer cells expressing low levels of cytokeratin 18.Anticancer bioactive peptide-3 inhibits human gastric cancer growth by suppressing gastric cancer stem cells.Circulating Cell Death Biomarkers May Predict Survival in Human Lung Transplantation.Methods to Evaluate Cell Growth, Viability, and Response to Treatment in a Tissue Engineered Breast Cancer Model.A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer.Safety, pharmacokinetics, and pharmacodynamics of the DR5 antibody LBY135 alone and in combination with capecitabine in patients with advanced solid tumors.Differential Proteome Analysis of Extracellular Vesicles from Breast Cancer Cell Lines by Chaperone Affinity Enrichment.

P2860

Q24614856-CB51E6D8-6D19-4F64-BD10-B61948F00D1C Q24653446-0986B87C-6DD9-4C2C-A730-35481EE8A1F4 Q27329087-94195203-043D-4812-90CD-5DEDE14286CE Q27345313-BB34D14E-754F-40DD-82E0-E94A775C1DC1 Q33413085-CBC12F8C-CBE6-47F2-872D-4E3451474DAD Q33420106-C7AFF892-A5F1-4073-8B04-273B92EE290E Q33658526-35BFE426-D135-4924-AA33-A513110989A1 Q33694691-4FEF94D0-56D3-4D91-9756-CD5B78E579FA Q33740667-7F76B45F-E142-4EA9-993B-ECDE41836C57 Q34101560-92C58781-D8F7-4F48-8EA7-49BE298CB1BD Q34698815-53766214-51E4-48A9-9222-BFBD3916CF32 Q35289072-D6B11E0F-43E6-42ED-B3E1-2959F243DE53 Q35624661-9D1D4B62-F9A4-49A1-80AB-349356A22BF5 Q35653933-EC99BFF3-88D9-469A-B65D-16E6BC0E2553 Q35941833-56727F08-EC53-4B89-93FF-A9D9B6E544F8 Q35998447-058F3B31-BE76-44DE-8101-1B3F2F2F268B Q36177752-A48C48FA-07A1-4375-BF4A-D1A4E4EA8218 Q36484621-0C1B6FE7-F084-43C0-A01F-EBACB0E68C7B Q36897795-BA0BEEAA-CA22-46F9-A2B1-18E6ED3D5A61 Q36980678-9412E979-6107-4DFE-8D69-E0795043C957 Q37111059-AE2F7EDB-E84A-4AEC-9188-3FD6BDECDC62 Q37188048-961B0CCE-27C6-4A53-8B2C-7282FE65A858 Q37278502-C4F08B60-BE7E-4FAC-B272-2B2269258687 Q37287486-1F190454-9270-45EC-A5BB-CB4F199695F5 Q37400048-FC926199-4EB7-41A7-B6D9-CDC1B0A04C07 Q37446412-734A492D-CC36-4E95-B037-967719BE57E1 Q37690073-1CA82631-7608-4A28-A3EE-4D2F4B7E61F5 Q37724878-0D18C5FD-D2CF-4616-B5AC-588F8136500C Q37755150-EF946672-D741-4D98-9ED0-3A0BE73D4C09 Q37942090-80907A0C-1340-4211-AA0B-02FBF79CD32B Q37960202-5EA73E4D-8A0C-4CDA-B347-681209440C9B Q38212434-9EC31A0C-974F-42F6-ADE2-801ECE8BF09C Q38702353-B423658C-7692-4892-BE0C-4C824908F022 Q38890416-CA154974-0076-4788-978E-A98F24E7D049 Q39064767-3EE0C69E-F175-43EC-B787-28CD296F2155 Q40077102-3F13E6F4-872F-4F0C-99ED-5DDE189B490E Q42621191-FF34BA2B-12AC-47A0-A914-11712A222AEB Q43421009-0A6F4444-2C89-4C2A-8406-AFA82D0A39CA Q46326788-2A94346D-8468-4B55-9ED4-AB35DAD45DFF Q47239080-C19FEBE7-B1E4-4B87-9FC9-86B050E5AF61

P2860

Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy

http://www.wikidata.org/entity/Q28304865

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

name

Cytokeratin-18 is a useful ser ...... ast carcinomas to chemotherapy

@ast

Cytokeratin-18 is a useful ser ...... ast carcinomas to chemotherapy

@en

Cytokeratin-18 is a useful ser ...... ast carcinomas to chemotherapy

@nl

type

label

Cytokeratin-18 is a useful ser ...... ast carcinomas to chemotherapy

@ast

Cytokeratin-18 is a useful ser ...... ast carcinomas to chemotherapy

@en

Cytokeratin-18 is a useful ser ...... ast carcinomas to chemotherapy

@nl

prefLabel

Cytokeratin-18 is a useful ser ...... ast carcinomas to chemotherapy

@ast

Cytokeratin-18 is a useful ser ...... ast carcinomas to chemotherapy

@en

Cytokeratin-18 is a useful ser ...... ast carcinomas to chemotherapy

@nl

P1433

Q28304865-50756C46-DE39-43E5-BFA6-47A3668F6C65

P1476

Q28304865-E9DCC320-BE51-4359-9F61-87E2F0027F73

P2093

Q28304865-0FD39028-1D4F-4825-8209-460F180E4968

Q28304865-188219B4-9428-4270-AAA1-F67A601540D3

Q28304865-219BA2C6-93B9-4C20-BC1B-81A4CF407891

Q28304865-2C5AE317-436C-455B-ACD2-C4E374BF6B53

Q28304865-4A4CB468-C623-4509-8344-F85E5714FCF1

Q28304865-59001CF7-9EA2-47BF-9BEE-DE1B14C868DC

Q28304865-5B416310-50D6-4D85-95F6-70B456898300

Q28304865-5F4F7ED7-2B66-4D69-8F60-BEB32573E5C9

Q28304865-93EF5C5F-2FDF-47AF-B40A-4279D6A6A9CB

Q28304865-D8CA9D10-D817-4FDE-9D60-C5037887946F

P304

Q28304865-AFC54AC0-629E-4720-9A6A-3CA0D9B3ECAF

P31

Q28304865-9F6585B6-248C-43DF-B14D-4D8D7AD095CE

P3181

Q28304865-808BB0D9-B8E8-4740-B8E5-95C6180D17B9

P356

Q28304865-E6FEE63B-B53C-4FAB-B9C4-56938BC2E058

P407

Q28304865-1803C73A-7742-4AE0-80C5-DF5AF097FF44

P433

Q28304865-6FEDDF7F-2601-479B-B0C8-BF037F9CB83C

P478

Q28304865-E5621E89-EE32-4644-86B6-55D7663BFE60

P50

Q28304865-0B6AB40E-49DA-4896-8750-C67282D69189

Q28304865-4B2C431D-062C-461F-9AE4-CBE26810A790

P577

Q28304865-C6602D1E-7013-4186-A260-5C4882158929

P5875

Q28304865-D7940413-500A-43FF-9085-7D3A765FBE3C

P698

Q28304865-27893B26-71B2-46BC-BBA4-224FE95EB49C

P921

Q28304865-12BC1A64-1941-4086-AEA5-6E0ACD88ECD4

Q28304865-9E994284-B724-4EE2-975D-CCF141832378

P3181

P356

1078-0432.CCR-07-0009

P1433

Clinical Cancer Research

P1476

Cytokeratin-18 is a useful ser ...... ast carcinomas to chemotherapy

@en

P2093

Aleksandra Mandic Havelka

http://www.w3.org/2001/XMLSchema#string

Elina Andersson

http://www.w3.org/2001/XMLSchema#string

Feng Cai

http://www.w3.org/2001/XMLSchema#string

Heiko van der Kuip

http://www.w3.org/2001/XMLSchema#string

Maike Sonnenberg

http://www.w3.org/2001/XMLSchema#string

Maria C Shoshan

http://www.w3.org/2001/XMLSchema#string

Maria Hägg Olofsson

http://www.w3.org/2001/XMLSchema#string

Masakazu Toi

http://www.w3.org/2001/XMLSchema#string

Ren Xu

http://www.w3.org/2001/XMLSchema#string

Stephan Schwarz

http://www.w3.org/2001/XMLSchema#string

P304

3198-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2120267

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1078-0432.CCR-07-0009

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Heiko van der Kuip

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6290096

http://www.w3.org/2001/XMLSchema#string

P698

17545523

http://www.w3.org/2001/XMLSchema#string

P921